Načítá se...
The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronically elevated liver enzymes. Diagnosis and risk stratification of NAFLD remains clinically challenge as patients with NAFLD are either asymptomatic or have nonspecific presenting complaints and may have normal liver enzymes....
Uloženo v:
| Vydáno v: | Endocrinol Diabetes Metab |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7576290/ https://ncbi.nlm.nih.gov/pubmed/33102796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.127 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|